VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 110-113

  Essa, S ^a   Denzer, N ^a   Mahlknecht, U ^a   Klein, R ^b   Collnot, E M ^c   Tilgen, W ^a   Reichrath, J ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SEQ IT GmbH amp Co KG   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Epigenetic silencing; Malignant melanoma; MicroRNA; Vitamin D

Indexed keywords

AZACITIDINE; CALCITRIOL; MICRORNA; TRICHOSTATIN A; CALCITRIOL RECEPTOR; VITAMIN D;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MELANOMA CELL; METASTASIS; PROGNOSIS; SIGNAL TRANSDUCTION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; MELANOMA; METABOLISM; SKIN TUMOR; TIME; TUMOR CELL LINE;

AZACITIDINE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MELANOMA; MICRORNAS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TIME FACTORS; VITAMIN D;

EID: 77954758485     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.02.003     Document Type: Article

References (13)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics, 2007. CA Cancer J. Clin. 2007, 57:43-66.
2. Eigentler T.K., Caroli U.M., Radny P., Garbe C. Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncol. 2003, 4(12):748-759.
3. Grabacka M., Plonka P.M., Urbanska K., Reiss K. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt. Clin. Cancer Res. 2006, 12(10):3028-3036.
4. 3 and its analogues. Cell Death Differ. 1998, 5(11):946-952.
5. 3 and its analogs on growth control and tumorigenesis. Front. Biosci. 2001, 6:820-848.
6. 3 on melanoma cell lines in vitro. J. Steroid Biochem. Mol. Biol. 2004, 89-90:375-379.
7. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 1979, 209:1189-1190.
8. Mohri T., Nakajima M., Takagi S., Komagata S., Yokoi T. MicroRNA regulates human vitamin D receptor. J. Int. J. Cancer 2009, 125(6):1328-1333.
9. 3 and agents that increase intracellular adenosine 3',5'-monophosphate synergistically inhibit fibroblast proliferation, in vitro. Cell. Dev. Biol. 1997, 33(4):310-314.
10. 3 and agents that increase intracellular adenosine 3',5'-monophosphate synergistically inhibit the mitogeneic stimulation of human lymphocytes. J. Clin. Endocrinol. Metab. 1990, 70(6):1678-1692.
11. Gallagher W.M., Bergin O.E., Rafferty M., Kelly Z.D., Nolan I.M., Fox E.J.P., Culhane A.C., McArdle L., Fraga M.F., Hughes L., Currid C.A., O'Mahony F., Byrne A., Murphy A.A., Moss C., McDonnell S., Stallings R.L., Plumb J.A., Esteller M., Brown R., Dervan P.A., Easty D.J. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 2005, 26(11):1856-1867.
12. Flørenes V.A., Skrede M., Jørgensen K., Nesland J.M. Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival. Melanoma Res. 2004, 14(3):173-181.
13. 3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. J. Steroid Biochem. Mol. Biol. 2004, 89-90(1-5):245-249.